• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部应用诺氟沙星与妥布霉素治疗眼部外感染的安全性和有效性。

Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.

作者信息

Jacobson J A, Call N B, Kasworm E M, Dirks M S, Turner R B

机构信息

Division of Infectious Diseases, LDS Hospital, Salt Lake City, Utah.

出版信息

Antimicrob Agents Chemother. 1988 Dec;32(12):1820-4. doi: 10.1128/AAC.32.12.1820.

DOI:10.1128/AAC.32.12.1820
PMID:3072923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176025/
Abstract

Bacterial conjunctivitis appears to resolve more rapidly when treated with appropriate topical antimicrobial agents. In this multicenter, randomized, double-blind study of efficacy and safety, patients with presumed bacterial external eye infections were assigned to topical therapy with 0.3% norfloxacin or 0.3% tobramycin. A total of 120 patients were enrolled. Of the total, 65 had documented bacterial infections and were evaluable; 59 of these patients had bacterial conjunctivitis. All of the patients with documented infections were cured or improved regardless of the drug treatment regimen or in vitro susceptibility testing results. The most common bacteria isolated were Haemophilus influenzae, Streptococcus pneumoniae, alpha-hemolytic streptococci, Staphylococcus aureus, and Staphylococcus sp. No patients had serious adverse reactions attributed to their therapy. Norfloxacin ophthalmic solution seems to be a safe, effective, and appropriate agent for the treatment of bacterial external eye infections.

摘要

使用适当的局部抗菌药物治疗时,细菌性结膜炎似乎能更快痊愈。在这项关于疗效和安全性的多中心、随机、双盲研究中,疑似细菌性外眼感染患者被分配接受0.3%诺氟沙星或0.3%妥布霉素的局部治疗。总共招募了120名患者。其中,65例有记录的细菌感染且可进行评估;这些患者中有59例患有细菌性结膜炎。所有有记录感染的患者无论药物治疗方案或体外药敏试验结果如何均已治愈或病情改善。分离出的最常见细菌为流感嗜血杆菌、肺炎链球菌、α溶血性链球菌、金黄色葡萄球菌和葡萄球菌属。没有患者因治疗出现严重不良反应。诺氟沙星滴眼液似乎是治疗细菌性外眼感染的一种安全、有效且合适的药物。

相似文献

1
Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.局部应用诺氟沙星与妥布霉素治疗眼部外感染的安全性和有效性。
Antimicrob Agents Chemother. 1988 Dec;32(12):1820-4. doi: 10.1128/AAC.32.12.1820.
2
Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions.
Eur J Ophthalmol. 1996 Jul-Sep;6(3):287-92. doi: 10.1177/112067219600600312.
3
Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.
Eur J Ophthalmol. 1995 Apr-Jun;5(2):82-7. doi: 10.1177/112067219500500203.
4
Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.
Arch Ophthalmol. 1992 Sep;110(9):1234-7. doi: 10.1001/archopht.1992.01080210052022.
5
Tobramycin in external eye disease: a double-masked study vs. gentamicin.
Curr Eye Res. 1981;1(5):259-66. doi: 10.3109/02713688108999445.
6
Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis.
Eur J Ophthalmol. 1994 Jan-Mar;4(1):6-12. doi: 10.1177/112067219400400102.
7
Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group.
Am J Ophthalmol. 1992 Jun 15;113(6):638-44. doi: 10.1016/s0002-9394(14)74787-7.
8
The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group.
Eye (Lond). 1992;6 ( Pt 1):111-4. doi: 10.1038/eye.1992.23.
9
Efficacy of norfloxacin in bacterial conjunctivitis.诺氟沙星在细菌性结膜炎中的疗效。
Eur J Ophthalmol. 1991 Apr-Jun;1(2):69-72. doi: 10.1177/112067219100100203.
10
Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.1.5%阿奇霉素滴眼液3天治疗化脓性细菌性结膜炎的微生物学疗效
Eur J Ophthalmol. 2008 Nov-Dec;18(6):858-68. doi: 10.1177/112067210801800602.

引用本文的文献

1
Interventions for preventing ophthalmia neonatorum.预防新生儿眼炎的干预措施。
Cochrane Database Syst Rev. 2020 Sep 21;9(9):CD001862. doi: 10.1002/14651858.CD001862.pub4.
2
Case of isolated Rhizobium radiobacter contact lens-related infectious keratitis: A plant microbe now emerging as a human pathogen.孤立的根癌土壤杆菌所致隐形眼镜相关感染性角膜炎病例:一种现正成为人类病原体的植物微生物。
Am J Ophthalmol Case Rep. 2019 May 30;15:100476. doi: 10.1016/j.ajoc.2019.100476. eCollection 2019 Sep.
3
Interventions for chronic blepharitis.慢性睑缘炎的干预措施。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD005556. doi: 10.1002/14651858.CD005556.pub2.
4
The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.莫西沙星滴眼液在治疗细菌性结膜炎中的作用。
Clin Drug Investig. 2011;31(8):543-557. doi: 10.2165/11589020-000000000-00000.
5
Acute infectious conjunctivitis in childhood.儿童急性感染性结膜炎
Paediatr Child Health. 2001 Jul;6(6):329-35. doi: 10.1093/pch/6.6.329.
6
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.1.5%阿奇霉素滴眼液3天疗法与0.3%妥布霉素7天疗法治疗脓性细菌性结膜炎:成人及儿童多中心随机对照试验
Br J Ophthalmol. 2007 Apr;91(4):465-9. doi: 10.1136/bjo.2006.103556. Epub 2006 Oct 18.
7
Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.疑似微生物性角膜炎治疗结果的危险因素。氧氟沙星研究组。
Br J Ophthalmol. 1999 Sep;83(9):1027-31. doi: 10.1136/bjo.83.9.1027.
8
Pharmacokinetic considerations in the treatment of bacterial keratitis.细菌性角膜炎治疗中的药代动力学考量
Clin Pharmacokinet. 1994 Aug;27(2):129-49. doi: 10.2165/00003088-199427020-00005.
9
Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora.局部用环丙沙星和诺氟沙星滴眼液的眼部穿透性及其对眼睑菌群的影响。
Br J Ophthalmol. 1994 Jul;78(7):546-8. doi: 10.1136/bjo.78.7.546.

本文引用的文献

1
Anaerobic and aerobic bacterial flora of acute conjunctivitis in children.儿童急性结膜炎的厌氧和需氧细菌菌群
Arch Ophthalmol. 1980 May;98(5):833-5. doi: 10.1001/archopht.1980.01020030827003.
2
Etiology of acute conjunctivitis in children.儿童急性结膜炎的病因
J Pediatr. 1981 Apr;98(4):531-6. doi: 10.1016/s0022-3476(81)80754-8.
3
Efficacy of topical antibiotic therapy in acute conjunctivitis in children.局部抗生素治疗儿童急性结膜炎的疗效
J Pediatr. 1984 Apr;104(4):623-6. doi: 10.1016/s0022-3476(84)80566-1.
4
Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.诺氟沙星与诺氟沙星银治疗兔铜绿假单胞菌角膜溃疡
Trans Am Ophthalmol Soc. 1984;82:75-91.
5
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).诺氟沙星(MK - 0366,AM - 715)纸片扩散药敏试验的暂行解释标准。
Antimicrob Agents Chemother. 1983 Feb;23(2):256-60. doi: 10.1128/AAC.23.2.256.
6
Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates.局部用诺氟沙星治疗的潜力。对临床眼部细菌分离株的体外活性比较。
Arch Ophthalmol. 1987 Jul;105(7):991-4. doi: 10.1001/archopht.1987.01060070135043.
7
Tobramycin in ophthalmology.妥布霉素在眼科中的应用。
Surv Ophthalmol. 1987 Sep-Oct;32(2):111-22. doi: 10.1016/0039-6257(87)90103-2.
8
In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.诺氟沙星及其他药物对眼部病原体的体外抗菌活性。
Chemotherapy. 1985;31(2):112-8. doi: 10.1159/000238322.
9
Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity.
Am J Med. 1987 Jun 26;82(6B):3-17. doi: 10.1016/0002-9343(87)90612-7.
10
Rapid detection of herpes simplex virus in clinical specimens by centrifugation and immunoperoxidase staining.通过离心和免疫过氧化物酶染色快速检测临床标本中的单纯疱疹病毒。
J Clin Microbiol. 1986 Apr;23(4):683-6. doi: 10.1128/jcm.23.4.683-686.1986.